The growing field of biological therapy relies heavily on recombinant mediator technology, and a thorough understanding of individual profiles is paramount for refining experimental design and therapeutic efficacy. Specifically, examining the characteristics of recombinant IL-1A, IL-1B, IL-2, and IL-3 highlights notable differences in their structu